| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/15/2009 | WO2009007409A2 Oil in water emulsion comprising nsaids and quaternary ammonium halides |
| 01/15/2009 | WO2009007389A1 Stable pharmaceutical composition of a water-soluble vinorelbine salt |
| 01/15/2009 | WO2009007388A1 Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt |
| 01/15/2009 | WO2009007376A1 Pharmaceutical compositions for peroral administration of phenothiazine dyestuffs |
| 01/15/2009 | WO2009007341A2 Topical composition containing adapalene for the treatment of keratini zation disorders |
| 01/15/2009 | WO2009007334A2 Transdermal therapeutic systems which contain the substance anastrozole |
| 01/15/2009 | WO2009007273A2 A colouring composition comprising starch derivatives as a hydrocolloid |
| 01/15/2009 | WO2009007137A2 Pharmaceutical composition for topical application of poorly soluble compounds |
| 01/15/2009 | WO2009007110A2 Combination of benzyl-4,5-dihydro-1h-imidazole derivative and an opiod recptor ligand |
| 01/15/2009 | WO2009006899A1 Compressed chewing gum tablet comprising taste-masking agent |
| 01/15/2009 | WO2009006898A1 Stable medicated chewing gum comprising cyclodextrin inclusion complex |
| 01/15/2009 | WO2009006892A1 Stable medicated chewing gum comprising antioxidant |
| 01/15/2009 | WO2009006792A1 Collagen-based microspheres and methods of preparation and use thereof |
| 01/15/2009 | WO2009006787A1 Composition comprising rotigotine, its use and transdermal patch comprising the composition |
| 01/15/2009 | WO2008138974A3 Occlusion instruments comprising bioresorbable radiopaque polymeric materials, as well as related products, methods and uses |
| 01/15/2009 | WO2008134912A4 Means for the application of active substances in the ear canal of a patient |
| 01/15/2009 | WO2008133952A3 Transmucosal treatment with fentanyl in patients with mucositis |
| 01/15/2009 | WO2008130803A3 Pulmonary delivery of spherical insulin microparticles |
| 01/15/2009 | WO2008128191A3 Oral cephalotaxine dosage forms |
| 01/15/2009 | WO2008115597A3 Cytokine muteins and methods for enhancing immune responses in mammals |
| 01/15/2009 | WO2008109031A3 Liposome carriers for in vivo delivery of fullerenes |
| 01/15/2009 | WO2008107149A3 Pharmaceutical form with impeded abuse |
| 01/15/2009 | WO2008102136A3 Solid pharmaceutical and vaccine dose |
| 01/15/2009 | WO2008077614A3 Use of a composition made of mineral nutrients and optionally acetogenic and/or butyrogenic bacteria in order to avoid or reduce the formation of gas in the large intestine of a mammal and the resulting abdominal problems |
| 01/15/2009 | WO2008068656A3 Dermatological compositions |
| 01/15/2009 | WO2008066810A3 Pleasant tasting dry powder compositions suitable for pulmonary delivery |
| 01/15/2009 | WO2008063581A3 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| 01/15/2009 | WO2008060890A3 Darusentan oral dosage form |
| 01/15/2009 | WO2008016404A3 Parathyroid hormone analogues and uses thereof |
| 01/15/2009 | WO2007144143A8 Method for preparing polymeric matrices by radiation in the presence of sensitive pharmaceutical compounds |
| 01/15/2009 | WO2007119028A9 Composition including at least one aqueous phase and at least one fatty phase including ivermectin |
| 01/15/2009 | WO2007089912A3 Methods of making medical devices |
| 01/15/2009 | WO2007075799A3 Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| 01/15/2009 | WO2007070168A3 Cosmetic compositions with encapsulated pigments and a method for using |
| 01/15/2009 | WO2005087199A3 Stabilised supersaturated solid solutions of steroidal drugs |
| 01/15/2009 | US20090018413 Implantable medical device for diagnostic sensing |
| 01/15/2009 | US20090018208 Novel Succinate Salt of O-Desmethyl-Venlafaxine |
| 01/15/2009 | US20090018190 Compositions and Methods for Transdermal Oxybutynin Therapy |
| 01/15/2009 | US20090018085 Use of a GnRH antagonist peptide in the treatment of sex hormone-dependent diseases |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018057 OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES |
| 01/15/2009 | US20090018053 Formulations for amylin agonist peptides |
| 01/15/2009 | US20090017133 Pharmaceutical formulation comprising lanthanum compounds |
| 01/15/2009 | US20090017127 once-daily oral administration relief of muscle spasm associated with painful musculoskeletal conditions over 24 hours; patient compliance, side effect reduction |
| 01/15/2009 | US20090017126 Modified Release Dosage Forms of Skeletal Muscle Relaxants |
| 01/15/2009 | US20090017125 Drug carrier pellet production process |
| 01/15/2009 | US20090017124 Nucleic Acid Microparticles for Pulmonary Delivery |
| 01/15/2009 | US20090017123 Dermal regeneration enhancer |
| 01/15/2009 | US20090017122 Drug Forms Having Controlled Bioavailability |
| 01/15/2009 | US20090017121 dispersed in a polymerc matrix comprising swellable hydrophilic polyethylene oxide that swells unrestrained dimensionally by imbibing H2O to increase its size to promote gastric retention of the dosage form in a stomach in fed mode, upon contact with H2O gabapentin released by diffusion; bioavailability |
| 01/15/2009 | US20090017120 Phase stable lecithin organogel composition |
| 01/15/2009 | US20090017119 Modifications of solid 3-sn-phosphoglycerides |
| 01/15/2009 | US20090017118 Coated tablets, their methods of preparation, and related uses |
| 01/15/2009 | US20090017117 Pellet formulation for the treatment of the intestinal tract |
| 01/15/2009 | US20090017116 Extended release gliclazide formulations |
| 01/15/2009 | US20090017115 Removal of material from a preformed tablet |
| 01/15/2009 | US20090017114 Tranexamic acid formulations with reduced adverse effects |
| 01/15/2009 | US20090017113 Duloxetine formulations |
| 01/15/2009 | US20090017112 Compounds for Inhibiting Beta-Amyloid Production |
| 01/15/2009 | US20090017111 Tolterodine bead |
| 01/15/2009 | US20090017110 Modified release formulations of anti-irritability drugs |
| 01/15/2009 | US20090017109 Method of reducing somnolence in patients treated with tizanidine |
| 01/15/2009 | US20090017108 Liposome compositions for treatment of hepatitis C |
| 01/15/2009 | US20090017107 Novel composition to increase libido |
| 01/15/2009 | US20090017106 Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions |
| 01/15/2009 | US20090017105 Proliposomal and liposomal compositions of poorly water soluble drugs |
| 01/15/2009 | US20090017104 Compositions containing retinoid and beta-aminoisobutyic acid derivatives |
| 01/15/2009 | US20090017103 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 01/15/2009 | US20090017102 Enhancing transdermal delivery of opiod antagonists and agonistis using codrugs links to bupropion or hydroxybupropion |
| 01/15/2009 | US20090017101 Compositions for removing stains from dental surfaces and methods of making and using the same |
| 01/15/2009 | US20090017100 Pharmaceutical composition, food or drink, or feed for intestinal disease |
| 01/15/2009 | US20090017098 Composition and method for the prevention and relief of the symptoms of an incompetent or patulous eustachian tube |
| 01/15/2009 | US20090017097 Hydrogel polymeric compositions and methods |
| 01/15/2009 | US20090017093 Gelatinous material for filling bone and/or cartilage defects |
| 01/15/2009 | US20090017091 Sterile hyaluronic acid polymer compositions and related methods |
| 01/15/2009 | US20090017089 Multiple active agents such as anthelmintics sustained release delivery device |
| 01/15/2009 | US20090017085 Self-supporting films for pharmaceutical and food use |
| 01/15/2009 | US20090017084 skin-friendly formulations comprising permethrin and agonists or antagonists of nicotinic acetylcholine receptors of insects, in particular imidacloprid, for controlling parasitic insects on animals |
| 01/15/2009 | US20090017083 Bioswellable sutures |
| 01/15/2009 | US20090017078 Anhydrous topical formulation for polyphenols |
| 01/15/2009 | US20090017075 Immunomodulatory compositions, methods of making, and methods of use thereof |
| 01/15/2009 | US20090016971 Aqueous fluid photoprotective compositions comprising tertiary-amide-terminated polyamide polymers |
| 01/15/2009 | US20090016970 Continuous spray scalp therapy and dispensing systems for same |
| 01/15/2009 | US20090016969 Pharmaceutical composition for topical application of poorly soluble compounds |
| 01/15/2009 | US20090016967 Compositions and methods for the treatment of respiratory disorders |
| 01/15/2009 | US20090016962 Compositions and methods for the treatment of cancer |
| 01/15/2009 | US20090013998 Inhalable tiotropium and container therefor |
| 01/15/2009 | US20090013652 Method and Apparatus for Loading a Container with a Product |
| 01/15/2009 | CA2730221A1 Oil in water emulsion comprising nsaids and quaternary ammonium halides |
| 01/15/2009 | CA2696435A1 A composition to impart benefit agents to anionic substrates and methods of its use |
| 01/15/2009 | CA2696139A1 Materials and methods for delivering compositions to selected tissues |
| 01/15/2009 | CA2695040A1 Stable pharmaceutical composition of a water-soluble vinorelbine salt |
| 01/15/2009 | CA2695039A1 Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt |
| 01/15/2009 | CA2694277A1 Stable formulations of thiadiazole derivatiive |
| 01/15/2009 | CA2693644A1 Chitosan carboxyalkylamide hydrogel, preparation thereof and cosmetic and dermatological use thereof |
| 01/15/2009 | CA2693613A1 Acellular tissue matrix compositions for tissue repair |
| 01/15/2009 | CA2693609A1 Oral pharmaceutical solutions containing telbivudine |
| 01/15/2009 | CA2693061A1 Compositions for topical application for the treatment of keratinization disorders |
| 01/15/2009 | CA2692884A1 Dermal delivery device with in situ seal |